Skip to main content


The demand for outsourcing of the testing services among pharmaceutical and biopharmaceutical businesses has also risen. The demand for new in silico modelling techniques in making is a key driver for growth in opportunities for contract research organizations (CROS) in the pharmaceutical analytical testing outsourcing market. Among various technologies to this end, CROs are increasingly leveraging physiologically-based pharmacokinetics (PBPK).